Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating abaloparatide vs placebo in postmenopausal women and abaloparatide in men undergoing initial spinal fusion su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tymlos (abaloparatide)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Spinal Fusion | Phase 2 | Status: RECRUITING